image
Iovance Biotherapeutics, Inc. IOVA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.03
1 %
$ 993 M
Market Cap
-2.37
P/E
BALANCE SHEET
910 M ASSETS
16.67%
Growth Rates
1Year 16.67%
3Years 5.41%
5Years 21.44%
7Years 28.73%
10Years 34.64%
200 M LIABILITIES
2.19%
Growth Rates
1Year 2.19%
3Years 8.71%
5Years 34.36%
7Years 53.65%
10Years 61.45%
710 M EQUITY
21.52%
Growth Rates
1Year 21.52%
3Years 4.55%
5Years 18.90%
7Years 25.43%
10Years 31.82%
BALANCE SHEET DECOMPOSITION
Balance Sheet Iovance Biotherapeutics, Inc.
image
Current Assets 457 M
Cash & Short-Term Investments 324 M
Receivables 69.3 M
Other Current Assets 63.9 M
Non-Current Assets 453 M
Long-Term Investments 0
PP&E 164 M
Other Non-Current Assets 289 M
35.56 %7.62 %7.02 %18.04 %31.76 %Total Assets$910.4m
Current Liabilities 122 M
Accounts Payable 27.5 M
Short-Term Debt 12.9 M
Other Current Liabilities 81.9 M
Non-Current Liabilities 77.7 M
Long-Term Debt 44.4 M
Other Non-Current Liabilities 33.3 M
13.75 %6.45 %40.96 %22.18 %16.66 %Total Liabilities$200.0m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008
ASSETS
Cash & Cash Equivalents 115.7 114.9 231.7 78.2 67.3 14.0 82.2 145.4 166.5 103.7 44.9 19.7 5 K 0.5 1.3 8.26 K 2.9 K
Short Term Investments 208.1 165.0 240.1 426.2 562.1 293.1 386.4 0 59.8 90.1 0 0 5 K 9.39 K 0 0 0
Receivables 69.3 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 51.5 10.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 12.4 17.5 7.3 7.1 13.3 18.8 13.7 7.8 6.1 0.6 0.1 0.2 7.28 K 4.47 K 3.45 K 150 0
Total Current Assets 457.0 307.8 471.8 508.0 636.1 312.5 475.4 149.3 169.5 104.0 45.0 19.8 7.28 K 0.5 1.3 8.41 K 3.06 K
PP&E 164.3 176.5 178.2 169.9 113.9 19.2 2.7 2.5 2.4 1.7 1.5 27.8 K 22.1 K 28.3 K 0.2 0 2.56 K
Intangible Assets 282.4 229.3 0 0 0 0 0 0 0 0 0 0 0 0 0.2 1.22 K 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 6.4 91.6 5.5 5.5 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 6.7 66.7 (178.2) 7.9 12.9 7.4 2.8 3.6 0 0 0 0 22.1 K 16 K (0.2) 0 0
Other Assets 0 0 185.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 910.4 780.4 664.0 777.3 768.5 344.7 480.8 155.4 171.9 105.7 46.5 19.9 29.4 K 0.6 1.5 9.63 K 5.61 K
LIABILITIES
Accounts Payable 27.5 33.1 26.6 27.4 13.5 15.6 2.7 1.2 0.9 1.0 1.2 0.4 1.1 0.2 30.3 K 0 0
Short Term Debt 12.9 7.8 25.2 10.1 12.6 14.5 0 0 0 0 0 0 6.5 5.0 0 0 0
Other Current Liabilities 81.9 69.4 39.7 51.7 28.8 9.0 11.7 8.4 4.1 0.7 0.4 1.9 3.8 8.2 0.8 23.1 K 3.33 K
Total Current Liabilities 122.3 110.3 91.5 89.2 54.9 39.1 14.4 9.9 5.0 1.6 1.7 2.3 11.3 13.3 0.8 23.1 K 3.33 K
Long Term Debt 44.4 68.1 72.9 66.5 90.8 8.5 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 32.3 17.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 1.0 0 0 0 (33.7) (1.9) 0.2 0.3 0 0 0 0 0 0 0 0 0
Total Liabilities 200.0 195.7 164.3 155.7 112.0 45.7 14.6 9.9 5.0 1.6 1.7 2.3 11.3 13.3 0.8 23.1 K 3.33 K
EQUITY
Common Stock 13 K 11 K 8 K 7 K 6 K 5 K 5 K 3 K 3 K 2 K 1.41 K 835 3.41 K 3.25 K 3.07 K 5.06 K 5.06 K
Retained Earnings (2 384.6) (2 012.4) (1 568.3) (1 172.4) (830.2) (570.6) (372.8) (249.2) (157.1) (104.2) (76.6) (64.5) (30.7) (27.4) (1.7) 74.5 K 58.7 K
Other Accumulative Comprehensive Income/Loss (1.0) 2.5 (0.9) (0.6) 19 K 0.2 42 K 0 29 K 48 K (0.1) 16 K 8.92 K 2.7 K 0 0 0
Total Equity 710.4 584.6 499.6 621.7 656.5 299.0 466.2 145.5 166.9 104.0 44.8 17.6 (11.3) (12.8) 0.6 13.5 K 2.28 K
Total Liabilities and Equity 910.4 780.4 664.0 777.3 768.5 344.7 480.8 155.4 171.9 105.7 46.5 19.9 29.4 K 0.6 1.5 9.63 K 5.61 K
SHARES OUTSTANDING
Common Shares Outstanding 289.9 235.1 159.3 153.4 138.3 124.3 97.3 65.2 55.3 44.4 25.0 9.8 0.8 0.8 0.7 0.4 1.2